Work

Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma

Year: 2019

Type: article

Study design: Observational Study

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2019.11.012

Authors: Ruby Gupta, Moshe Chaim Ornstein, Hong Li, Kimberly D. Allman, Laura S. Wood, Timothy Gilligan, Jorge A. Garcia, Dendra Von Merveldt, Hans J. Hammers, Brian I. Rini

Institutions: Cleveland Clinic, The University of Texas Southwestern Medical Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Pfizer, GlaxoSmithKline, Merck, Novartis, Exelixis, Bayer Fund, Eisai

OpenAlex ID: W2991737181

FWCI: 5.782

Cites: 19

Cited by: 69

Related to: 10